February 27, 2026 · Form 4 insider transaction
Krishnan Suma bought 18,100 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The stock options vest in four equal annual installments beginning on February 27, 2027.